Peter Svennilson

Affiliations

  • at Rapt Therapeutics Inc. (RAPT), 2024-12-23
  • Large Shareholder at Ngm Biopharmaceuticals Inc (NGM), 2024-04-09
  • Large Shareholder at Oric Pharmaceuticals Inc. (ORIC), 2021-11-16
  • Large Shareholder at Effector Therapeutics Inc. (EFTR), 2021-09-07
  • Large Shareholder at Nurix Therapeutics Inc. (NRIX), 2021-05-07
  • Director at Revolution Medicines Inc. (RVMD), 2021-04-28
  • Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2021-02-19
  • Large Shareholder, Director at Gritstone Oncology Inc. (GRTS), 2019-06-20
  • Large Shareholder, Other at Immune Design Corp. (IMDZ), 2019-04-03
  • Large Shareholder at Arcus Biosciences Inc. (RCUS), 2018-03-19
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NGM $14.95 112,602 $1,683,399.90 17,706,978 2020-04-08 Filing
NGM $14.38 123,728 $1,779,208.64 17,594,376 2020-04-07 Filing
NGM $12.41 14,587 $181,024.67 17,470,648 2020-04-03 Filing
NGM $12.40 14,850 $184,140.00 17,456,061 2020-04-02 Filing
NGM $12.26 118,067 $1,447,501.42 17,441,211 2020-04-01 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RVMD $42.50 53 $2,252.50 1,775,236 2021-04-28 Filing
RVMD $42.50 47 $1,997.50 1,571,963 2021-04-28 Filing
RVMD $42.65 12,371 $527,659.03 1,775,289 2021-04-27 Filing
RVMD $42.65 10,955 $467,262.52 1,572,010 2021-04-27 Filing
RVMD $42.85 28,101 $1,204,026.69 1,787,660 2021-04-26 Filing